🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Palvella Therapeutics, Inc. (PVLA)
NASDAQ: PVLA · Real-Time Price · USD
146.94
+1.17 (0.80%)
Nov 20, 2026, 11:55 AM EST - Market open

Palvella Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22
2,1481,239135--
Market Cap Growth
122.29%820.07%---
Enterprise Value
1,9371,191215--
Last Close Price
145.77104.6712.00--

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22
PB Ratio
10.7644.272.15--
P/TBV Ratio
10.7844.272.15--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22
Debt / Equity Ratio
0.130.660.19-2.08-1.40
Net Debt / Equity Ratio
-1.07-1.41-1.14-0.18-0.71
Quick Ratio
15.885.117.143.112.78
Current Ratio
16.015.207.333.202.86
Return on Equity (ROE)
-63.39%-92.10%-59.37%--
Return on Assets (ROA)
-28.68%-32.65%-18.39%-61.63%-
Return on Capital Employed (ROCE)
-31.30%-80.10%-18.50%-228.80%-167.90%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22
Earnings Yield
-3.79%-3.37%-12.95%--
Buyback Yield / Dilution
-46.67%-405.46%-24.08%68.63%-
SEC Filings: 10-K · 10-Q